Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73 (1):202–9.

Article  PubMed  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64 (1):73–84.

Article  PubMed  Google Scholar 

Pierantonelli I, Svegliati-Baroni G. Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH. Transplantation. 2019;103 (1):e1–13.

Article  PubMed  CAS  Google Scholar 

National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. J Pract Hepatol. 2018;2018 (21):177–86.

Google Scholar 

Nan Y, An J, Bao J, Chen H, Chen Y, Ding H, et al. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol. 2021;75 (2):454–61.

Article  PubMed  CAS  Google Scholar 

Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, et al. Chronic hepatitis B and non-alcoholic fatty liver disease: conspirators or competitors? Liver Int. 2020;40 (3):496–508.

Article  PubMed  Google Scholar 

Jiangao F, Jing Z. Epidemic status and harm of non alcoholic fatty liver disease. Chin J Dig. 2020;40 (9):577–80.

Google Scholar 

Shaojie D, Zunjing L, Jialiang C, Shukun Y. Value of lipid accumulation product and visceral fat index in predicting nonalcoholic fatty liver disease. J Clin Hepatol. 2022;38 (01):129–34.

Google Scholar 

Xiaolian G, Mingzhong X, Junxiu T, Yating A. Characteristics analysis of predictive models of nonalcoholic fatty liver disease. Chin Gen Pract. 2021;24 (30):3888–92, 99.

Google Scholar 

Ismaiel A, Jaaouani A, Leucuta DC, Popa SL, Dumitrascu DL. The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis-systematic review and meta-analysis. Biomedicines. 2021. https://doi.org/10.3390/biomedicines9121890.

Article  PubMed  PubMed Central  Google Scholar 

Jia H, Shuxia G, Jiaming L, Mei Z, Yusong D. Ethnic differences in prevalence of general obesity and abdominal obesity among low-income rural Kazakh and Uyghur adults in far western China and implications in preventive public health. PLoS ONE. 2014;9 (9): e106723.

Article  Google Scholar 

American Diabetes Association. Executive summary: standards of medical care in diabetes–2012. Diabetes Care. 2012;35 (Suppl 1):S4–10.

Google Scholar 

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

Article  PubMed  PubMed Central  Google Scholar 

Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42 (7):503–8.

Article  PubMed  CAS  Google Scholar 

Bedogni G, Henry SK, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010;10:98.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Xu C, Xun Y, Lu Z, Shi J, Yu C, et al. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015;5:16494.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33 (4):920–2.

Article  PubMed  PubMed Central  Google Scholar 

Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40 (12):3018–30.

Article  PubMed  CAS  Google Scholar 

Chen WZ, Ni ZZ, Pan XP, Liu YY, Xia Y. Receiver operating characteristic curves to determine the optimal operating point and doubtable value interval. Mod Prevent Med. 2005;7:729–31.

Google Scholar 

Chen YL, Li H, Li S, Xu Z, Tian S, Wu J, et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 2021;21 (1):212.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70 (4):1119–33.

Article  PubMed  Google Scholar 

Wang WQ, Wei B, Song YP, Guo H, Zhang XH, Wang XP, et al. Metabolically healthy obesity and unhealthy normal weight rural adults in Xinjiang: prevalence and the associated factors. BMC Public Health. 2021;21 (1):1940.

Article  PubMed  PubMed Central  Google Scholar 

Zhai F, He Y, Wang Z, Hu Y. Status and characteristic of dietary intake of 12 minority nationalities in China. Wei Sheng Yan Jiu. 2007;36 (5):539–41.

PubMed  Google Scholar 

Wang Y, Zhang L, He J, Yan Y. Relationship between blood pressure and obesity in adults of remote rural areas of Xinjiang. Chin J Hypertens. 2016;24 (07):650–6.

Google Scholar 

He J, Guo H, Ding Y, Liu J, Zhang M, Ma R, et al. Epidemiological study on overweight and obesity among rural adult residents in Hazakh, Uygur and Han populations in Xinjiang. Chin J Epidemiol. 2013;34 (12):1164–8.

Google Scholar 

Frayn KN. Visceral fat and insulin resistance: causative a correlative. Br J Nutr. 2000;83 (Suppl. 1):S71–7.

Article  PubMed  CAS  Google Scholar 

Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in man. J Clin Invest. 1995;96:88–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Olubamwo OO, Virtanen JK, Pihlajamaki J, Mantyselka P, Tuomainen TP. Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort. BMJ Open. 2019;9 (9): e031420.

Article  PubMed  PubMed Central  Google Scholar 

Olubamwo OO, Virtanen JK, Pihlajamaki J, Tuomainen TP. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study. BMJ Open. 2019;9 (7): e026949.

Article  PubMed  PubMed Central  Google Scholar 

Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Mori K, Miyamori D, et al. Elevated fatty liver index is independently associated with new onset of hypertension during a 10-year period in both male and female subjects. J Am Heart Assoc. 2021;10 (14): e021430.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, et al. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Sci Rep. 2021;11 (1):8606.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Sakamoto K, Azuma M, et al. Hepatic steatosis index and chronic kidney disease among middle-aged individuals: a large-scale study in Japan. Dis Markers. 2021;2021:9941834.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Cai Z, Deng X, Li H, Zhao Z, Guo C, et al. Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes. Int J Med Sci. 2021;18 (14):3280–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ozcabi B, Demirhan S, Akyol M, Ozturkmen Akay H, Guven A. Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. Korean J Pediatr. 2019;62 (12):450–5.

Article  PubMed  PubMed Central  Google Scholar 

Zhang M, Zheng L, Li P, Zhu Y, Chang H, Wang X, et al. 4-Year trajectory of visceral adiposity index in the development of type 2 diabetes: a prospective cohort study. Ann Nutr Metab. 2016;69 (2):142–9.

Article  PubMed  CAS  Google Scholar 

Ji B, Qu H, Wang H, Wei H, Deng H. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population. Acta Diabetol. 2016;53 (5):817–23.

Article  PubMed  CAS  Google Scholar 

Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11 (9):1201–4.

Article  PubMed  Google Scholar 

Yang BL, Wu WC, Fang KC, Wang YC, Huo TI, Huang YH, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE. 2015;10 (3): e0120443.

Article  PubMed  PubMed Central  Google Scholar 

Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore). 2015;94 (40): e1682.

Article  PubMed  CAS